The Prostate Specific Membrane Antigen (PSMA), a type II transmembrane glycoprotein of the prostate secretory acinar epithelium, is upregulated in prostate carcinoma and its metastasis [11–13]. The gene discussed is FOLH1; the disease is prostate carcinoma.